# Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma.

> **NCT07280234** · EARLY_PHASE1 · COMPLETED · sponsor: **Hayat Abad Medical Complex, Peshawar** · enrollment: 218 (actual)

## Conditions studied

- Melasma

## Interventions

- **DRUG:** Intradermal microinjections of tranexamic acid
- **DRUG:** Oral tranexamic acid

## Key facts

- **NCT ID:** NCT07280234
- **Lead sponsor:** Hayat Abad Medical Complex, Peshawar
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-14
- **Primary completion:** 2025-05-15
- **Final completion:** 2025-05-15
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2025-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07280234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07280234, "Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07280234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
